Black Rock Inc. Brainstorm Cell Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 386,414 shares of BCLI stock, worth $471,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
386,414
Previous 489,313
21.03%
Holding current value
$471,425
Previous $274,000
52.19%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BCLI
# of Institutions
41Shares Held
10.8MCall Options Held
160KPut Options Held
30.5K-
Armistice Capital, LLC New York, NY6.9MShares$8.42 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.84 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA683KShares$833,0350.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$414,9830.01% of portfolio
-
Weaver Consulting Group234KShares$285,9140.02% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $44.5M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...